Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 16
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Lexaria Bioscience Corp
LEXX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$2.99
0.17
6.03%
Ult. Agg.: Oct 15, 7:34 PM
$3.16
0.34
12.06%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
Lexaria Bioscience Financials
Lexaria Bioscience (LEXX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Lexaria Bioscience Q3 EPS $(0.08) Beats $(0.09) Estimate
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 0 percent. This is a 61.9 percent increase over losses of $(0.21) per share from
Benzinga Newsdesk
PRO
Lexaria Bioscience Q2 EPS $(0.06) Beats $(0.11) Estimate, Sales $20.000K Miss $100.000K Estimate
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 60 percent increase over losses of $(0.15) per share from
Benzinga Newsdesk
Nasdaq Gains 100 Points; US Consumer Sentiment Falls
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.83% to 46,328.48 while the NASDAQ rose 0.45% to 22,484.92. The S&P 500 also rose, gaining, 0.62% to 6,645.73.
Avi Kapoor
Dow Jumps Over 250 Points; Fed's Key Inflation Gauge Remains Hot
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Friday. The Dow traded up 0.58% to 46,213.26 while the NASDAQ rose 0.31% to 22,455.17. The S&P 500 also rose, gaining, 0.47% to 6,636.07.
Avi Kapoor
PRO
Lexaria Bioscience Q3 EPS $(0.21) Misses $(0.16) Estimate, Sales $174.000K Beat $91.333K Estimate
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.16) by 33.76 percent. This is a 61.54 percent decrease over losses of $(0.13) per share
Benzinga Newsdesk
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results
Avi Kapoor
